Quadrature Capital »

Rapport Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $268k 8.8k 30.34

More positions owned by Quadrature Capital

Advanced Micro Devices (AMD)
UnitedHealth (UNH)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Canadian Natl Ry (CNI)
Sandisk Corp (SNDK)
Asml Holding N V N Y Registry Shs (ASML)
Ge Vernova (GEV)
Tesla Motors (TSLA)
Stellantis SHS (STLA)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Booking Holdings (BKNG)
Agnico (AEM)
Lockheed Martin Corporation (LMT)

View all positions for Quadrature Capital

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics